Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2017	Oct. 01, 2016
Cash flows from operating activities:
Net earnings	$ 733,826	$ 699,058
Adjustments to reconcile net earnings to net cash provided by operating activities:
Restructuring	27,099	28,300
Tradename impairment	0	47,905
Depreciation and amortization	328,300	305,088
Deferred income taxes	16,549	(27,887)
Loss (gain) on disposal of property, plant and equipment	2,221	(10,849)
Stock-based compensation expense	30,607	28,841
Changes in operating assets and liabilities, net of effects of acquisitions:
Receivables, net	(166,775)	(255,311)
Inventories	(121,970)	(53,578)
Other assets and prepaid expenses	(1,668)	67,375
Accounts payable and accrued expenses	26,343	170,274
Other liabilities	(310)	1,126
Net cash provided by operating activities	874,222	1,000,342
Cash flows from investing activities:
Additions to property, plant and equipment	(654,630)	(460,760)
Acquisitions, net of cash acquired	(250,766)	0
Net cash used in investing activities	(905,396)	(460,760)
Cash flows from financing activities:
Payments on Senior Credit Facilities	(317,162)	(467,618)
Proceeds from Senior Credit Facilities	267,263	386,551
Payments on Commercial Paper	(11,385,287)	(17,614,864)
Proceeds from Commercial Paper	11,587,228	17,835,126
Proceeds from Floating Rate Notes	357,569	0
Repayment of Senior Notes	0	(645,555)
Payments of other debt and financing costs	(15,493)	0
Payments on asset securitization borrowings	(500,000)	0
Debt issuance costs	(1,400)	(1,086)
Change in outstanding checks in excess of cash	(5,004)	(1,924)
Shares redeemed for taxes	(12,255)	(11,879)
Proceeds and net tax benefit from stock transactions	1,204	4,367
Net cash used in financing activities	(23,337)	(516,882)
Effect of exchange rate changes on cash and cash equivalents	17,348	7,716
Net change in cash and cash equivalents	(37,163)	30,416
Cash and cash equivalents, beginning of period	121,665	81,692
Cash and cash equivalents, end of period	$ 84,502	$ 112,108